GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sol-Gel Technologies Ltd (NAS:SLGL) » Definitions » Common Stock

Sol-Gel Technologies (Sol-Gel Technologies) Common Stock : $0.77 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Sol-Gel Technologies Common Stock?

Sol-Gel Technologies's quarterly common stock stayed the same from Sep. 2023 ($0.77 Mil) to Dec. 2023 ($0.77 Mil) and stayed the same from Dec. 2023 ($0.77 Mil) to Mar. 2024 ($0.77 Mil).

Sol-Gel Technologies's annual common stock stayed the same from Dec. 2021 ($0.64 Mil) to Dec. 2022 ($0.64 Mil) but then increased from Dec. 2022 ($0.64 Mil) to Dec. 2023 ($0.77 Mil).


Sol-Gel Technologies Common Stock Historical Data

The historical data trend for Sol-Gel Technologies's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sol-Gel Technologies Common Stock Chart

Sol-Gel Technologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only 0.56 0.64 0.64 0.64 0.77

Sol-Gel Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.71 0.77 0.77 0.77 0.77

Sol-Gel Technologies Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Sol-Gel Technologies (Sol-Gel Technologies) Business Description

Traded in Other Exchanges
Address
7 Golda Meir Street, Weizmann Science Park, Ness Ziona, ISR, 7403650
Sol-Gel Technologies Ltd is a clinical-stage specialty pharmaceutical company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.

Sol-Gel Technologies (Sol-Gel Technologies) Headlines